Company · CIK 1933567
Neuraxis, INC
| CIK | 1933567 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 3845 — Electromedical & Electrotherapeutic Apparatus |
| Incorporated in | DE |
| Business address | IN |
| Listed | NRXS (NYSE) |
| First annual or quarterly report | 2023-09-22 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-297651 | 2026-07-23 | 2026-08-03 | 2 | |
| 333-283798 | 2024-12-13 | 2026-04-21 | 6 | |
| 333-269179 | 2023-01-10 | 2023-08-11 | 11 |
Filings
20| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-08-03 | EFFECTDeclared effective | 333-297651 | 9999999995-26-002528 |
| 2026-07-23 | S-3Shelf registered | 333-297651 | 0001493152-26-034417 |
| 2026-04-21 | 424B5Shelf takedown | 333-283798 | 0001493152-26-018361 |
| 2025-10-23 | 424B5Shelf takedown | 333-283798 | 0001493152-25-019133 |
| 2025-08-29 | 424B5Shelf takedown | 333-283798 | 0001641172-25-026009 |
| 2025-05-22 | 424B5Shelf takedown | 333-283798 | 0001641172-25-011970 |
| 2025-02-11 | EFFECTDeclared effective | 333-283798 | 9999999995-25-000390 |
| 2024-12-13 | S-3Shelf registered | 333-283798 | 0001493152-24-049984 |
| 2023-08-11 | 424B4Final prospectus | 333-269179 | 0001493152-23-027743 |
| 2023-08-08 | EFFECTDeclared effective | 333-269179 | 9999999995-23-002302 |
| 2023-07-28 | S-1/AAmendment | 333-269179 | 0001493152-23-025900 |
| 2023-07-21 | S-1/AAmendment | 333-269179 | 0001493152-23-025136 |
| 2023-06-29 | S-1/AAmendment | 333-269179 | 0001493152-23-022884 |
| 2023-06-01 | S-1/AAmendment | 333-269179 | 0001493152-23-019787 |
| 2023-02-13 | S-1/AAmendment | 333-269179 | 0001493152-23-004534 |
| 2023-02-13 | S-1/AAmendment | 333-269179 | 0001493152-23-004377 |
| 2023-02-06 | S-1/AAmendment | 333-269179 | 0001493152-23-003681 |
| 2023-01-26 | S-1/AAmendment | 333-269179 | 0001493152-23-002577 |
| 2023-01-10 | S-1Registration filed | 333-269179 | 0001493152-23-001110 |
| 2022-09-27 | DRSDraft made public | 377-06383 | 0001493152-22-026904 |